{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:22:08Z","timestamp":1792182128030,"version":"4.4.0"},"reference-count":61,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Mycosis fungoides (MF) and S\u00e9zary syndrome (SS) can impair multiple dimensions of health-related quality of life (HRQoL). Currently, there is no standardized assessment tool for measuring HRQoL in patients with MF\/SS. Here, we describe the existing literature on multiple dimensions of HRQoL in MF\/SS with a special focus on the gaps in the current knowledge and identify future directions necessary to assess the HRQoL of patients with this disease.<\/jats:p>","DOI":"10.3390\/cancers16152757","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T11:28:54Z","timestamp":1722857334000},"page":"2757","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Assessing Health-Related Quality of Life in Mycosis Fungoides and S\u00e9zary Syndrome: Unmet Needs"],"prefix":"10.3390","volume":"16","author":[{"given":"Danielle","family":"Brazel","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, Scripps Clinic\/Scripps Green Hospital, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Larocca","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Department of Dermatology, Dana Farber Cancer Center, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michi M.","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Washington, 1959 Northeast Pacific Street BB-1353, Box 356524, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1080\/10428190310001623766","article-title":"Cutaneous T-cell lymphoma: Epidemiology, etiology, and classification","volume":"44","author":"Willemze","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: Recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jdv.18852","article-title":"Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: An EORTC-CLTG\/ISCL survey","volume":"37","author":"Quaglino","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tarabadkar, E.S., and Shinohara, M.M. (2019). Skin Directed Therapy in Cutaneous T-Cell Lymphoma. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00260"},{"key":"ref_7","first-page":"573","article-title":"How we treat mycosis fungoides and S\u00e9zary syndrome","volume":"19","author":"Khan","year":"2021","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"ref_8","unstructured":"(2024, June 01). NCCN Clinical Practice Guidelines for T-Cell Lymphoma. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/t-cell.pdf."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Fayers, P.M., and Machin, D. (2015). Quality of Life: The Assessment, Analysis and Reporting of Patient-Reported Outcomes, Wiley Blackwell. [3rd ed.].","DOI":"10.1002\/9781118758991"},{"key":"ref_10","first-page":"e99","article-title":"A brief history of the Quality of Life: Its use in medicine and in philosophy","volume":"162","author":"Pennacchini","year":"2011","journal-title":"Clin. Ter."},{"key":"ref_11","unstructured":"(2024, June 01). FDA Guidance for Industry, Available online: https:\/\/www.fda.gov\/media\/77832\/download."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/cncr.22252","article-title":"Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: Results of a 2005 National Cutaneous Lymphoma Foundation Survey","volume":"107","author":"Demierre","year":"2006","journal-title":"Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8019.2008.00170.x","article-title":"The psychosocial and occupational impact of chronic skin disease","volume":"21","author":"Hong","year":"2008","journal-title":"Dermatol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2013.446","article-title":"The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions","volume":"134","author":"Hay","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0190-9622(03)01136-8","article-title":"Quality of life issues in psoriasis","volume":"49","author":"Choi","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bjd.20765","article-title":"A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16","volume":"186","author":"Brodszky","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/pon.3591","article-title":"Illness perceptions of cancer patients: Relationships with illness characteristics and coping","volume":"24","author":"Hopman","year":"2015","journal-title":"Psychooncology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.abd.2020.05.008","article-title":"Illness perception, coping, and quality of life in early-stage Mycosis fungoides","volume":"96","author":"Segal","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1365-2133.2008.09014.x","article-title":"Illness perceptions, coping and quality of life in patients with alopecia","volume":"160","author":"Cartwright","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bjd.13259","article-title":"The role of beliefs: Lessons from a pilot study on illness perception, psychological distress and quality of life in patients with primary cicatricial alopecia","volume":"172","author":"Chiang","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e11302","DOI":"10.2196\/11302","article-title":"Measurement of Quality of Life in Patients with Mycosis Fungoides\/S\u00e9zary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument","volume":"21","author":"McCaffrey","year":"2019","journal-title":"J. Med. Internet Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2008.08992.x","article-title":"Quality of life and psychological distress in patients with cutaneous lymphoma","volume":"160","author":"Sampogna","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2340\/00015555-3171","article-title":"Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future","volume":"99","author":"Jonak","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archderm.141.3.325","article-title":"Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma","volume":"141","author":"Demierre","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0889-8588(03)00111-4","article-title":"Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma","volume":"17","author":"Demierre","year":"2003","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0889-8588(18)30056-X","article-title":"Assessing clinical outcomes in cutaneous T-cell lymphoma","volume":"9","author":"Zackheim","year":"1995","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1002\/ski2.45","article-title":"Health-related quality of life in cutaneous T-cell lymphoma: A cross-sectional survey study","volume":"1","author":"Shinohara","year":"2021","journal-title":"Skin Health Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2340\/00015555-2642","article-title":"Tailoring the Cut-off Values of the Visual Analogue Scale and Numeric Rating Scale in Itch Assessment","volume":"97","author":"Reich","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/jdv.16021","article-title":"Clinical severity measures and quality-of-life burden in patients with mycosis fungoides and S\u00e9zary syndrome: Comparison of generic and dermatology-specific instruments","volume":"34","author":"Herbosa","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jpainsymman.2012.01.012","article-title":"Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma","volume":"45","author":"Wright","year":"2013","journal-title":"J. Pain. Symptom Manag."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/07357907.2016.1194427","article-title":"Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma","volume":"34","author":"Beaven","year":"2016","journal-title":"Cancer Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/jdv.17570","article-title":"Quality of life in patients with Mycosis Fungoides and S\u00e9zary Syndrome: A systematic review of the literature","volume":"35","author":"Ottevanger","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5021\/ad.2012.24.4.406","article-title":"Effect of the pruritus on the quality of life: A preliminary study","volume":"24","author":"Erturk","year":"2012","journal-title":"Ann. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1007\/s00520-021-06241-6","article-title":"The impact of gender, age, race\/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas","volume":"29","author":"Martinez","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdermsci.2020.02.010","article-title":"Skindex-29 scores indicate poor quality of life in early stage mycosis fungoides","volume":"98","author":"Shalabi","year":"2020","journal-title":"J. Dermatol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1007\/s11606-023-08380-4","article-title":"Health-Related Quality of Life Scores and Values as Predictors of Mortality: A Scoping Review","volume":"38","author":"Chappell","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S1478951509990216","article-title":"Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients","volume":"7","author":"Grande","year":"2009","journal-title":"Palliat. Support. Care"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.2112043","article-title":"Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease","volume":"166","author":"Lamarca","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s11606-008-0783-x","article-title":"Predictors of mortality in patients with stable COPD","volume":"23","author":"Esteban","year":"2008","journal-title":"J. Gen. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/ggi.12225","article-title":"Quality of life by proxy and mortality in institutionalized older adults with dementia","volume":"15","author":"Forjaz","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2133.2002.04622.x","article-title":"A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy","volume":"146","author":"Fortune","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40425-018-0346-6","article-title":"Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: Retrospective review at MD Anderson","volume":"6","author":"Wang","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1182\/blood-2022-166887","article-title":"Mogamulizumab-Associated Rash (MAR) Correlates with Longer Progression Free Survival in Cutaneous T Cell Lymphoma (CTCL)","volume":"140","author":"Hu","year":"2022","journal-title":"Blood"},{"key":"ref_44","first-page":"633","article-title":"Racial Disparities in the Clinical Presentation and Prognosis of Patients with Mycosis Fungoides","volume":"111","author":"Huang","year":"2019","journal-title":"J. Natl. Med. Assoc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clml.2013.12.018","article-title":"Poorer prognosis of African-American patients with mycosis fungoides: An analysis of the SEER dataset, 1988 to 2008","volume":"14","author":"Nath","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaad.2017.01.016","article-title":"Racial disparities in the impact of chronic pruritus: A cross-sectional study on quality of life and resource utilization in United States veterans","volume":"77","author":"Shaw","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/j.clml.2023.12.017","article-title":"Racial Disparities in Mycosis Fungoides\/S\u00e9zary Syndrome-A Single-Center Observational Study of 292 Patients","volume":"24","author":"Gandham","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamadermatol.2013.7696","article-title":"Factors mediating the impact of chronic pruritus on quality of life","volume":"150","author":"Carr","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_50","first-page":"e34054","article-title":"Perspectives on and Quality of Life in Skin of Color Patients With Mycosis Fungoides\/S\u00e9zary Syndrome: A Qualitative Analysis","volume":"15","author":"Abraham","year":"2023","journal-title":"Cureus"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaad.2021.01.026","article-title":"Gender differences in clinical presentation, treatment, and outcomes in mycosis fungoides","volume":"86","author":"Behbahani","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e0038","DOI":"10.5041\/RMMJ.10172","article-title":"Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy","volume":"5","author":"Horesh","year":"2014","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e085","DOI":"10.1097\/JW9.0000000000000085","article-title":"Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma","volume":"9","author":"Chalaka","year":"2023","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/bjd.18089","article-title":"Characteristics associated with significantly worse quality of life in mycosis fungoides\/S\u00e9zary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study","volume":"182","author":"Molloy","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12955-018-1007-7","article-title":"The association of socioeconomic and clinical characteristics with health-related quality of life in patients with psoriasis: A cross-sectional study","volume":"16","author":"Jung","year":"2018","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jdv.13689","article-title":"Quality of life and disease severity in patients with atopic dermatitis","volume":"30","author":"Holm","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/14768320500094177","article-title":"The impact of illness representations and disease activity on adjustment in women with rheumatoid arthritis: A longitudinal study","volume":"20","author":"Groarke","year":"2005","journal-title":"Psychol. Health"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/13548500601073928","article-title":"Illness perception in individuals with atopic dermatitis","volume":"12","author":"Wittkowski","year":"2007","journal-title":"Psychol. Health Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/bjd.13583","article-title":"\u2018We\u2019re all carrying a burden that we\u2019re not sharing\u2019: A qualitative study of the impact of cutaneous T-cell lymphoma on the family","volume":"172","author":"Selman","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-2133.2007.07794.x","article-title":"The family impact of skin diseases: The Greater Patient concept","volume":"156","author":"Basra","year":"2007","journal-title":"Br. J. Dermatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/15\/2757\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:29:25Z","timestamp":1760110165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/15\/2757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":61,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["cancers16152757"],"URL":"https:\/\/doi.org\/10.3390\/cancers16152757","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]}}}